August 2017. Ma N, Atukorale Y, Marlow N, Duncan J, Cameron A

This review examines the current evidence for the clinical efficacy, safety and cost-effectiveness of transcranial magnetic stimulation (TMS) for patients with major depression and/or schizophrenia. It also looks at evidence for its use within particular patient sub groups. It will be a useful resource when considering local implementation of TMS in NSW as a new health technology.  The quality of the evidence found was high however there was considerable variability, particularly for schizophrenia, in treatment protocols, scope, rigour and quality. To account for this the researchers undertook a high-level review of the entire evidence base with more detailed extraction of studies identified as being the most recent and most representative.